Dyne Therapeutics, Inc.
DYN
$17.92
$1.116.60%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/9/2026
-
Tickeron - Stocks
6/9/2026
-
Simply Wall St
6/8/2026
-
TipRanks
6/6/2026
-
Tickeron - Stocks
6/5/2026
-
Yahoo! Finance: News
6/5/2026
-
Simply Wall St
6/4/2026
-
TipRanks Financial Blog
6/3/2026
-
Globe Newswire
6/1/2026
-
Simply Wall St
5/31/2026
-
Simply Wall St
5/30/2026
-
Nasdaq News: Markets
5/30/2026
-
Fool.com Headlines
5/29/2026
-
MarketBeat
5/27/2026
-
Zacks Investment Research
5/27/2026
-
Nasdaq News: Stocks
5/26/2026
-
Globe Newswire
5/25/2026
-
MarketBeat
5/24/2026
-
The Cerbat Gem
5/23/2026
-
Simply Wall St
5/23/2026
-
The Cerbat Gem
5/21/2026
-
Seeking Alpha - Long Ideas
5/21/2026
-
SeekingAlpha
5/21/2026
-
Zacks Investment Research
5/21/2026
-
The Cerbat Gem
5/20/2026
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, May 11, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Jul 27 and 31 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 786 8230
Address
1560 Trapelo Road
Waltham, MA 02451
Waltham, MA 02451
Country
Year Founded
Business Description
Sector
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is...
more